Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer
Pavan P. Adiseshaiah, Rachael M. Crist, Sara S. Hook, et al.
Nature Reviews Clinical Oncology (2016) Vol. 13, Iss. 12, pp. 750-765
Open Access | Times Cited: 215

Showing 26-50 of 215 citing articles:

The life cycle of cancer-associated fibroblasts within the tumour stroma and its importance in disease outcome
Elisa D’Arcangelo, Nila C. Wu, Jose L. Cadavid, et al.
British Journal of Cancer (2020) Vol. 122, Iss. 7, pp. 931-942
Open Access | Times Cited: 98
Photosensitizer Nanoparticles Boost Photodynamic Therapy for Pancreatic Cancer Treatment
Huanyu Yang, Renfa Liu, Yunxue Xu, et al.
Nano-Micro Letters (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 96
Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite
Wei‐Siang Liao, Yu Chieh Ho, Yu-Wei Lin, et al.
Acta Biomaterialia (2019) Vol. 86, pp. 395-405
Closed Access | Times Cited: 94
Plasmon‐Driven Catalytic Chemotherapy Augments Cancer Immunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway
Yuan Ding, Zhongquan Sun, Yong Gao, et al.
Advanced Materials (2021) Vol. 33, Iss. 34
Closed Access | Times Cited: 88
From Design to Clinic: Engineered Nanobiomaterials for Immune Normalization Therapy of Cancer
Madiha Saeed, Fang‐Ming Chen, Jiayi Ye, et al.
Advanced Materials (2021) Vol. 33, Iss. 30
Open Access | Times Cited: 87
Cancer Cell Membrane-Camouflaged Nanorods with Endoplasmic Reticulum Targeting for Improved Antitumor Therapy
Wei Zhang, Miaorong Yu, Ziyue Xi, et al.
ACS Applied Materials & Interfaces (2019) Vol. 11, Iss. 50, pp. 46614-46625
Closed Access | Times Cited: 85
Black phosphorus: A novel nanoplatform with potential in the field of bio-photonic nanomedicine
Taojian Fan, Yansheng Zhou, Meng Qiu, et al.
Journal of Innovative Optical Health Sciences (2018) Vol. 11, Iss. 06
Open Access | Times Cited: 83
Dendrimeric nanosystem consistently circumvents heterogeneous drug response and resistance in pancreatic cancer
Juan Liu, Chao Chen, Tuo Wei, et al.
Exploration (2021) Vol. 1, Iss. 1, pp. 21-34
Open Access | Times Cited: 82
Nanomedicines inhibiting tumor metastasis and recurrence and their clinical applications
Xiangyi Kong, Ran Cheng, Jing Wang, et al.
Nano Today (2020) Vol. 36, pp. 101004-101004
Closed Access | Times Cited: 73
Stroma-Targeting Therapy in Pancreatic Cancer: One Coin With Two Sides?
Bolun Jiang, Li Zhou, Jun Lü, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 71
Nanoplatform-mediated calcium overload for cancer therapy
Junlie Yao, Hao Peng, Yue Qiu, et al.
Journal of Materials Chemistry B (2022) Vol. 10, Iss. 10, pp. 1508-1519
Closed Access | Times Cited: 39
Recent advances in nanotechnology approaches for non-viral gene therapy
Yihang Jiang, Miaozhuang Fan, Zhenxu Yang, et al.
Biomaterials Science (2022) Vol. 10, Iss. 24, pp. 6862-6892
Closed Access | Times Cited: 38
Promising Nanomedicines of Shikonin for Cancer Therapy
Chunmei Yan, Qiuxia Li, Qiang Sun, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 1195-1218
Open Access | Times Cited: 37
Advantages of Nanomedicine in Cancer Therapy: A Review
Chao Wang, Shan Zhang
ACS Applied Nano Materials (2023) Vol. 6, Iss. 24, pp. 22594-22610
Closed Access | Times Cited: 28
Conquering chemoresistance in pancreatic cancer: Exploring novel drug therapies and delivery approaches amidst desmoplasia and hypoxia
Pavan Kumar Chintamaneni, Sai Kiran S. S. Pindiprolu, Swati Swagatika Swain, et al.
Cancer Letters (2024) Vol. 588, pp. 216782-216782
Open Access | Times Cited: 10
Gemcitabine-Vitamin E Prodrug-Loaded Micelles for Pancreatic Cancer Therapy
Miguel Pereira‐Silva, Darío Miranda-Pastoriza, Luis Díaz‐Gómez, et al.
Pharmaceutics (2024) Vol. 16, Iss. 1, pp. 95-95
Open Access | Times Cited: 9
Histone deacetylase class-I inhibition promotes epithelial gene expression in pancreatic cancer cells in a BRD4- and MYC-dependent manner
Vivek Kumar Mishra, Florian Wegwitz, Robyn Laura Kosinsky, et al.
Nucleic Acids Research (2017) Vol. 45, Iss. 11, pp. 6334-6349
Open Access | Times Cited: 85
Photodynamic Priming Mitigates Chemotherapeutic Selection Pressures and Improves Drug Delivery
Huang‐Chiao Huang, Imran Rizvi, Joyce Liu, et al.
Cancer Research (2017) Vol. 78, Iss. 2, pp. 558-571
Open Access | Times Cited: 85
Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy
Eameema Muntimadugu, Nagavendra Kommineni, Wahid Khan
Pharmacological Research (2017) Vol. 126, pp. 109-122
Closed Access | Times Cited: 73
Recent advances in nanocarrier-loaded gels: Which drug delivery technologies against which diseases?
Marion Pitorre, Henri Gondé, Clotilde Haury, et al.
Journal of Controlled Release (2017) Vol. 266, pp. 140-155
Closed Access | Times Cited: 67
Delivery of miR-212 by chimeric peptide-condensed supramolecular nanoparticles enhances the sensitivity of pancreatic ductal adenocarcinoma to doxorubicin
Wei Chen, Yue Zhou, Xiao Zhi, et al.
Biomaterials (2018) Vol. 192, pp. 590-600
Open Access | Times Cited: 66
Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer
Johann Gout, Lukas Perkhofer, Mareen Morawe, et al.
Gut (2020) Vol. 70, Iss. 4, pp. 743-760
Open Access | Times Cited: 62
Clinical applications of nanomedicines in lung cancer treatment
Mohammad Norouzi, Pierre Hardy
Acta Biomaterialia (2020) Vol. 121, pp. 134-142
Closed Access | Times Cited: 62
Tumor-Targeting Polycaprolactone Nanoparticles with Codelivery of Paclitaxel and IR780 for Combinational Therapy of Drug-Resistant Ovarian Cancer
Qianqian Pan, Jingjun Tian, Huihui Zhu, et al.
ACS Biomaterials Science & Engineering (2020) Vol. 6, Iss. 4, pp. 2175-2185
Closed Access | Times Cited: 57
Intelligent nanogels with self-adaptive responsiveness for improved tumor drug delivery and augmented chemotherapy
Xin Li, Helin Li, Changchang Zhang, et al.
Bioactive Materials (2021) Vol. 6, Iss. 10, pp. 3473-3484
Open Access | Times Cited: 55

Scroll to top